Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2697

Actual shortage: 241 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2447 (91%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

330 (11%)

Overdue reports

26 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144494
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144497
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Actual shortage 2021-08-27 2022-08-18 144701
TEVA-TOBRAMYCIN 60MG SOLUTION Resolved 2021-10-14 2021-12-17 147231
TEVA-SALBUTAMOL STERINEBS P.F. 2MG SOLUTION Resolved 2021-10-21 2022-10-18 147717
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Resolved 2021-11-11 2021-12-11 149108
ACT PROGESTERONE INJECTION 50MG SOLUTION Actual shortage 2021-11-18 2022-08-18 149602
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-01-20 2022-04-21 153156
TEVA-IPRATROPIUM STERINEBS 250MCG SOLUTION Resolved 2022-01-20 2022-04-21 153165
TEVA-SALBUTAMOL STERINEBS P.F. 1MG SOLUTION Resolved 2022-01-20 2022-02-17 153186
TEVA-IPRATROPIUM STERINEBS 250MCG SOLUTION Resolved 2022-02-10 2022-07-01 154720
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-02-17 2022-03-24 155155
TEVA-IPRATROPIUM STERINEBS 250MCG SOLUTION Resolved 2022-04-28 2022-07-01 159590
TEVA-SALBUTAMOL STERINEBS P.F. 1MG SOLUTION Resolved 2022-06-16 2022-10-29 162858
TEVA-TOBRAMYCIN 60MG SOLUTION Resolved 2022-07-25 2022-12-08 165447
PEDIATRIX 160MG SOLUTION Resolved 2022-08-18 2023-06-27 167194
TEVA-TERIPARATIDE INJECTION 250MCG SOLUTION Resolved 2022-10-28 2022-12-15 173004
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-11-14 2023-01-12 174595
TEVA-COMBO STERINEBS 0.5MG 2.5MG SOLUTION Resolved 2022-12-01 2022-12-08 176827
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2023-01-12 2023-10-06 180891

Showing 781 to 800 of 2697

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-IRBESARTAN 75MG TABLET Discontinued 2024-04-01 2024-04-01 224049
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
TEVA-RABEPRAZOLE EC 20MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120015
TEVA-RABEPRAZOLE EC 10MG TABLET (DELAYED-RELEASE) Discontinued 2020-07-10 2020-07-10 120018
TEVA-PANTOPRAZOLE MAGNESIUM 40MG TABLET (DELAYED-RELEASE) Discontinued 2021-02-12 2021-02-12 133891
TEVA-DIVALPROEX 125MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97232
TEVA-DIVALPROEX 250MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97235
TEVA-DIVALPROEX 500MG TABLET (ENTERIC-COATED) Discontinued 2019-10-25 2019-10-26 97238
TEVA-DICLOFENAC EC 25MG TABLET (ENTERIC-COATED) Discontinued 2024-01-25 2024-01-26 217254
ACT OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63983
ACT OXYCODONE CR 20MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63986
ACT OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-12 2018-10-12 63989

Showing 221 to 240 of 250